Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Cash & Current Investments (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Cash & Current Investments of $143.0 million for Q1 2026, up 39.92% year-over-year from $102.2 million in Q1 2025, and down 13.14% quarter-over-quarter from $164.6 million in Q4 2025.

Stevanato Group S.p.A (STVN) Cash & Current Investments (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Cash & Current Investments for 7 consecutive years, with $143.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 39.92% year-over-year to $143.0 million; the TTM figure through Mar 2026 stood at $143.0 million (up 39.92% YoY), while the FY2025 annual figure was $164.6 million, up 54.63% from the prior year.
  • Cash & Current Investments declined to $143.0 million in Q1 2026 per STVN's latest filing, from $164.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $443.7 million in Q1 2022 and bottomed at $72.3 million in Q2 2023.
  • Historically, Cash & Current Investments has averaged $173.7 million across 5 years, with a median of $141.6 million in 2025.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments soared 1149584.78% — and 2023, when it tumbled 80.41%.
  • Stevanato Group S.p.A's Cash & Current Investments stood at $267.7 million in 2022, then plunged by 70.25% to $79.6 million in 2023, then soared by 33.67% to $106.4 million in 2024, then soared by 54.63% to $164.6 million in 2025, then fell by 13.14% to $143.0 million in 2026.
  • Business Quant data shows STVN's Cash & Current Investments at $143.0 million in Q1 2026, $164.6 million in Q4 2025, and $141.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 5.22 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 863.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 1.36 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 1.47 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 2.68 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 435.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 403.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 138.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 2.15 Bn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn 108.02 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 108.02 Mn
Mar 31, 2026 142.95 Mn
Dec 31, 2025 164.57 Mn
Sep 30, 2025 141.56 Mn
Jun 30, 2025 120.76 Mn
Mar 31, 2025 102.16 Mn
Dec 31, 2024 106.43 Mn
Sep 30, 2024 88.56 Mn
Jun 30, 2024 86.65 Mn
Mar 31, 2024 206.04 Mn
Dec 31, 2023 79.62 Mn
Sep 30, 2023 73.18 Mn
Jun 30, 2023 72.26 Mn
Mar 31, 2023 191.93 Mn
Dec 31, 2022 267.65 Mn
Sep 30, 2022 295.78 Mn
Jun 30, 2022 368.95 Mn
Mar 31, 2022 443.70 Mn
Dec 31, 2021 501.33 Mn
Sep 30, 2021 537.07 Mn